C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2006
11/15/2006	CN1863815A Polypeptides having brain disposition activity and utilization of the same
11/15/2006	CN1863556A Compositions and methods for treating coagulation related disorders
11/15/2006	CN1863555A Compositions and methods for manipulating levels antigen-specific antibodies in a mammal
11/15/2006	CN1863546A Methods for treating cardiovascular disease using a soluble ctla4 molecule
11/15/2006	CN1861632A Coupling compound of Norfloxacin, preparation process and application thereof
11/15/2006	CN1861631A Coupling compound of tetracycline, preparation process and application thereof
11/15/2006	CN1284860C Single clone antibody of antimutagen hepatitis B virus surface antigen and preparation method thereof
11/15/2006	CN1284622C Simulated activity of protein A displayed by ligands attached to cellulose bead surface
11/14/2006	US7135623 Nucleic acid(s) obtained from tetrahymena and which code(s) for a ciliate-specific delta-6-desaturase involved in biosynthesis of polyunsaturated fatty acids; hybridization; transgenic organisms; gene expression
11/14/2006	US7135612 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
11/14/2006	US7135556 NPC1L1 (NPC3) and methods of use thereof
11/14/2006	US7135555 Mammalian TNF-α convertases
11/14/2006	US7135552 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135340 Tetrameric antibody complexes for blocking non-specific labeling of antigens
11/14/2006	US7135335 Method for separating cells using immunorosettes
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006	US7135310 Method to amplify variable sequences without imposing primer sequences
11/14/2006	US7135303 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
11/14/2006	US7135301 Detection and treatment of prostate cancer
11/14/2006	US7135297 Isolated biopolymer marker peptide; using mass spectrometry to determine markers predictive of insulin resistance
11/14/2006	US7135295 Detection of small molecules by use of a piezoelectric sensor
11/14/2006	US7135281 Detecting viral infection of urogenital systems; tumor/cancer diagnosis
11/14/2006	US7135186 Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
11/14/2006	US7135185 Conserved motif of hepatitis C virus E2/NS1 region
11/14/2006	US7135182 Administration of substrates for transglutaminases or antibodies against such substrates; identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans
11/14/2006	US7135179 Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof
11/14/2006	US7135178 Methods of treating disseminated intravascular coagulation using anti-TNF antibodies
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells
11/14/2006	US7135174 Antibodies directed to PDGFD and uses thereof
11/14/2006	CA2239224C Topiramate immunoassay, as well as analogs and antibodies
11/14/2006	CA2227608C Polyvinyl alcohol-based magnetic polymer particles, methods for their preparation and their use
11/12/2006	CA2606334A1 Methods of using phhla2 to co-stimulate t-cells
11/09/2006	WO2006119464A1 Predicting treatment response in cancer subjects
11/09/2006	WO2006119291A2 Superantibody synthesis and use in detection, prevention and treatment of disease
11/09/2006	WO2006119285A1 Combination therapy in the treatment of cancer
11/09/2006	WO2006119115A2 Anti-il-6 antibodies, compositions, methods and uses
11/09/2006	WO2006119107A2 Sclerostin binding agents
11/09/2006	WO2006118522A1 Peptides as biomarkers of copd
11/09/2006	WO2006118350A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	WO2006118338A1 Diagnostic agent for tumor
11/09/2006	WO2006118313A1 Novel polypeptide and use thereof
11/09/2006	WO2006118289A1 Method for identification of compound having antidepressant effect
11/09/2006	WO2006117994A1 Antibody directed against gastrin-releasing peptide precursor and use thereof
11/09/2006	WO2006117910A1 Monoclonal antibody against platelet membrane glycoprotein vi
11/09/2006	WO2006117584A1 Antibody or a fragment thereof, having neutralizing activity against hiv
11/09/2006	WO2006117241A2 Polypeptide, vaccine and use thereof
11/09/2006	WO2006117194A2 Gpr18 as a biomaker for th1 mediated immune response
11/09/2006	WO2006117193A2 Receptor in dendritic cells
11/09/2006	WO2006117007A1 Methods for obtaining antigen specific antibodies
11/09/2006	WO2006096491A9 Anti-ctla-4 antibody compositions
11/09/2006	WO2006094704A3 Natural ligand of g protein coupled receptor rcc356 and uses thereof
11/09/2006	WO2006092631A3 Methyltransferases and their uses
11/09/2006	WO2005116236A3 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna
11/09/2006	WO2005089429A3 Sfec, a sperm flagellar energy carrier protein
11/09/2006	WO1998035042A8 Activity dependent neurotrophic factor iii (adnf iii)
11/09/2006	US20060253928 Optimizing glycan processing in plants
11/09/2006	US20060253912 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252691 Topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration of a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/09/2006	US20060252157 Larynx carcinoma-associated protein larcap-1
11/09/2006	US20060252130 Method for linking molecular substances
11/09/2006	US20060252124 Methods and compositions for generating human monoclonal antibodies
11/09/2006	US20060252107 Compositions and methods for diagnosing and treating retinal diseases
11/09/2006	US20060252106 Monoclonal antibodies and methods for their use in the detection of cervical disease
11/09/2006	US20060252105 Monoclonal antibody and hybridoma producing the same
11/09/2006	US20060252096 Single chain antibody with cleavable linker
11/09/2006	US20060252034 Novel protein containing ring finger domaine r1p4
11/09/2006	US20060252028 Method of assaying interaction between proteins
11/09/2006	US20060251668 Tumor-specific recognition molecules
11/09/2006	US20060251663 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tisssue permeability
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251658 Antibodies to TGF-beta
11/09/2006	US20060251655 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
11/09/2006	US20060251654 Method for treatment of malignant and infectious chronic diseases
11/09/2006	US20060251653 Methods for treating interleukin-6 related diseases
11/09/2006	US20060251652 Containing light and heavy chain variable regions with fully human germline frameworks; high binding affinity, and low dissociation rate; anticarcinogenic agents; Non-Hodgkin's lymphoma, Waldenstrom's macroglobulinemia
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251647 Quantitating the level of Apo-2 receptor expression in a biological sample to determine whether a patient has a disorder associated with an abnormal rate of apoptotic cell death
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251645 Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
11/09/2006	US20060251644 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies
11/09/2006	US20060251580 Lectin conjugates
11/09/2006	DE102005015832A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications
11/09/2006	CA2609640A1 Cellular assay method for identifying pkc-0 inhibitors
11/09/2006	CA2609561A1 Polypeptide, vaccine and use thereof
11/09/2006	CA2607327A1 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
11/09/2006	CA2607197A1 Sclerostin binding agents
11/09/2006	CA2606506A1 Superantibody synthesis and use in detection, prevention and treatment of disease
11/09/2006	CA2606489A1 Method for identification of compound having antidepressant effect
11/09/2006	CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	CA2606378A1 Fcrn antibodies and uses thereof
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2606008A1 Combination therapy in the treatment of cancer
11/09/2006	CA2605759A1 Antibodies directed against amyloid-beta peptide and methods using same
11/09/2006	CA2604608A1 Antibody directed against gastrin-releasing peptide precursor and use thereof
11/09/2006	CA2604440A1 Transgenic animals and methods of making recombinant antibodies
11/08/2006	EP1719780A2 Mammalian cytokine-like polypeptide-10
11/08/2006	EP1719779A2 Antibodies against Matin

1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 1494